TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1913517
log Bayes Factor = 0.0142305
Chromosome 10   position 50,119,054  (GRCh37) Explore rs1913517 on Ensembl!
Variant rs1913517 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
Y45.0 Opioids and related analgesics
0.192 0.808 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.189 0.811 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.180 0.820 0.000
Y45.1 Salicylates
0.176 0.824 0.000
Y45.2 Propionic acid derivatives
0.161 0.839 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.151 0.849 0.000
Y45.4 Antirheumatics
0.143 0.857 0.000
Y45.8 Other analgesics and antipyretics
0.129 0.871 0.000
Y45.5 4-Aminophenol derivatives
0.121 0.878 0.000
M48.02 Spinal stenosis (Cervical region)
0.051 0.949 0.000
M48.0 Spinal stenosis
0.028 0.972 0.000
M48.09 Spinal stenosis (Site unspecified)
0.026 0.974 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.024 0.976 0.000
Y42.5 Other oestrogens and progestogens
0.024 0.976 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.023 0.977 0.000
K31.9 Disease of stomach and duodenum, unspecified
0.000 0.978 0.022
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.022 0.978 0.000
M48.05 Spinal stenosis (Thoracolumbar region)
0.021 0.979 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.021 0.979 0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)
0.021 0.979 0.000
M48.04 Spinal stenosis (Thoracic region)
0.020 0.980 0.000
M48.03 Spinal stenosis (Cervicothoracic region)
0.020 0.980 0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)
0.020 0.980 0.000
Y42.9 Other and unspecified hormone antagonists
0.020 0.980 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.019 0.981 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.019 0.981 0.000
M48.07 Spinal stenosis (Lumbosacral region)
0.018 0.982 0.000
Y42.4 Oral contraceptives
0.018 0.982 0.000
Y52 Agents primarily affecting the cardiovascular system
0.017 0.983 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.017 0.983 0.000
Y59 Other and unspecified vaccines and biological substances
0.017 0.983 0.000
Y49.5 Other antipsychotics and neuroleptics
0.017 0.983 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.017 0.983 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.017 0.983 0.000
Y58 Bacterial vaccines
0.017 0.983 0.000
Y49.2 Other and unspecified antidepressants
0.017 0.983 0.000
H66.9 Otitis media, unspecified
0.016 0.984 0.000
H66 Suppurative and unspecified otitis media
0.016 0.984 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.016 0.984 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.016 0.984 0.000
H65-H75 Diseases of middle ear and mastoid
0.016 0.984 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.016 0.984 0.000
H69 Other disorders of Eustachian tube
0.016 0.984 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.016 0.984 0.000
Y48 Anaesthetics and therapeutic gases
0.016 0.984 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.016 0.984 0.000
Y42.1 Thyroid hormones and substitutes
0.016 0.984 0.000
H92.0 Otalgia
0.016 0.984 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.015 0.984 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.015 0.985 0.000
M48.06 Spinal stenosis (Lumbar region)
0.015 0.985 0.000
Y49.9 Psychotropic drug, unspecified
0.015 0.985 0.000
Y49.7 Psychostimulants with abuse potential
0.015 0.985 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.015 0.985 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.015 0.985 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.015 0.985 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.015 0.985 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.015 0.985 0.000
H70 Mastoiditis and related conditions
0.015 0.985 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.015 0.985 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.015 0.985 0.000
Y52.1 Calcium-channel blockers
0.015 0.985 0.000
H69.9 Eustachian tube disorder, unspecified
0.015 0.985 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.015 0.985 0.000
H69.8 Other specified disorders of Eustachian tube
0.015 0.985 0.000
H92 Otalgia and effusion of ear
0.014 0.986 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.014 0.986 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.014 0.986 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.014 0.986 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.013 0.986 0.001
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.014 0.986 0.000
Chapter VIII Diseases of the ear and mastoid process
0.014 0.986 0.000
Y42.2 Antithyroid drugs
0.013 0.986 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.986 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.986 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.986 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.013 0.986 0.000
Y51.0 Anticholinesterase agents
0.013 0.986 0.000
H70.9 Mastoiditis, unspecified
0.014 0.986 0.000
Y52.7 Peripheral vasodilators
0.013 0.986 0.000
H90-H95 Other disorders of ear
0.014 0.986 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.013 0.987 0.000
H66.2 Chronic atticoantral suppurative otitis media
0.013 0.987 0.000
Y42.7 Androgens and anabolic congeners
0.013 0.987 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.013 0.987 0.000
Y59.0 Viral vaccines
0.013 0.987 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.013 0.987 0.000
Y57 Other and unspecified drugs and medicaments
0.013 0.987 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.012 0.987 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.012 0.987 0.000
Y55.5 Anticommon cold drugs
0.012 0.987 0.000
Y55.4 Expectorants
0.012 0.987 0.000
Y55.3 Antitussives
0.012 0.987 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.012 0.987 0.000
Y55.0 Oxytocic drugs
0.012 0.987 0.000
Y59.9 Vaccine or biological substance, unspecified
0.012 0.987 0.000
Y59.8 Other specified vaccines and biological substances
0.012 0.987 0.000
Y59.2 Protozoal vaccines
0.012 0.987 0.000
Y59.1 Rickettsial vaccines
0.012 0.987 0.000
Y48.2 Other and unspecified general anaesthetics
0.012 0.987 0.000
Y50.9 Central nervous system stimulant, unspecified
0.012 0.987 0.000
Y50.8 Other central nervous system stimulants
0.012 0.987 0.000
Y50.1 Opioid receptor antagonists
0.012 0.987 0.000
Y50.0 Analeptics
0.012 0.987 0.000
Y54.4 Loop [high-ceiling] diuretics
0.013 0.987 0.000
Y59.3 Immunoglobulin
0.012 0.987 0.000
H71 Cholesteatoma of middle ear
0.012 0.987 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.012 0.988 0.000
Y58.9 Other and unspecified bacterial vaccines
0.012 0.988 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.012 0.988 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.012 0.988 0.000
Y58.5 Diphtheria vaccine
0.012 0.988 0.000
Y58.4 Tetanus vaccine
0.012 0.988 0.000
Y58.3 Plague vaccine
0.012 0.988 0.000
Y58.2 Cholera vaccine
0.012 0.988 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.012 0.988 0.000
H66.4 Suppurative otitis media, unspecified
0.012 0.988 0.000
H60.4 Cholesteatoma of external ear
0.012 0.988 0.000
Y41.1 Antimycobacterial drugs
0.012 0.988 0.000
Y58.0 BCG vaccine
0.012 0.988 0.000
H66.0 Acute suppurative otitis media
0.012 0.988 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.012 0.988 0.000
H60 Otitis externa
0.012 0.988 0.000
H70.1 Chronic mastoiditis
0.012 0.988 0.000
H70.8 Other mastoiditis and related conditions
0.012 0.988 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.012 0.988 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.012 0.988 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.012 0.988 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.012 0.988 0.000
Y47.4 Bromine compounds
0.012 0.988 0.000
Y47.3 Paraldehyde
0.012 0.988 0.000
Y47.2 Chloral derivatives
0.012 0.988 0.000
Y47.0 Barbiturates, not elsewhere classified
0.012 0.988 0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.012 0.988 0.000
H67 Otitis media in diseases classified elsewhere
0.012 0.988 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.012 0.988 0.000
H69.0 Patulous Eustachian tube
0.012 0.988 0.000
Y48.3 Local anaesthetics
0.012 0.988 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.011 0.988 0.000
Y41.4 Anthelminthics
0.011 0.988 0.000
Y41.3 Other antiprotozoal drugs
0.011 0.988 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.011 0.988 0.000
Y41.0 Sulphonamides
0.011 0.988 0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
0.012 0.988 0.000
Y48.5 Therapeutic gases
0.011 0.988 0.000
Y48.1 Parenteral anaesthetics
0.011 0.988 0.000
Y48.0 Inhaled anaesthetics
0.011 0.988 0.000
H60-H62 Diseases of external ear
0.012 0.988 0.000
H74 Other disorders of middle ear and mastoid
0.012 0.988 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.011 0.988 0.000
Y53.7 Emetics
0.011 0.988 0.000
Y53.6 Antidiarrhoeal drugs
0.011 0.988 0.000
Y53.5 Digestants
0.011 0.988 0.000
Y53.3 Saline and osmotic laxatives
0.011 0.988 0.000
Y53.2 Stimulant laxatives
0.011 0.988 0.000
Y53.0 Histamine H2-receptor antagonists
0.011 0.988 0.000
M48.00 Spinal stenosis (Multiple sites in spine)
0.011 0.988 0.000
H72 Perforation of tympanic membrane
0.012 0.988 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.011 0.989 0.000
H70.2 Petrositis
0.011 0.989 0.000
H70.0 Acute mastoiditis
0.011 0.989 0.000
Y54.9 Mineral salts, not elsewhere classified
0.011 0.989 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.011 0.989 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.011 0.989 0.000
Y54.0 Mineralocorticoids
0.011 0.989 0.000
Y46.7 Anti-Parkinsonism drugs
0.011 0.989 0.000
H68 Eustachian salpingitis and obstruction
0.011 0.989 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.011 0.989 0.000
Y47.1 Benzodiazepines
0.011 0.989 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.010 0.989 0.000
H92.2 Otorrhagia
0.011 0.989 0.000
Y46.8 Antispasticity drugs
0.011 0.989 0.000
Y46.5 Valproic acid
0.011 0.989 0.000
Y46.3 Deoxybarbiturates
0.011 0.989 0.000
Y46.1 Oxazolidinediones
0.011 0.989 0.000
Y46.0 Succinimides
0.011 0.989 0.000
H60.5 Acute otitis externa, non-infective
0.011 0.989 0.000
H92.1 Otorrhoea
0.011 0.989 0.000
Y54.8 Agents affecting uric acid metabolism
0.011 0.989 0.000
Y57.8 Other drugs and medicaments
0.011 0.989 0.000
Y46.4 Iminostilbenes
0.010 0.989 0.000
H73 Other disorders of tympanic membrane
0.011 0.989 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.011 0.989 0.000
Y54.7 Agents affecting calcification
0.010 0.989 0.000
Y54.3 Benzothiadiazine derivatives
0.010 0.990 0.000
Y46.6 Other and unspecified antiepileptics
0.010 0.990 0.000
Y56.3 Emollients, demulcents and protectants
0.010 0.990 0.001
H60.9 Otitis externa, unspecified
0.010 0.990 0.000
H60.0 Abscess of external ear
0.010 0.990 0.000
H72.8 Other perforations of tympanic membrane
0.010 0.990 0.000
Y56.9 Topical agent, unspecified
0.010 0.990 0.001
Y56.8 Other topical agents
0.010 0.990 0.001
Y56.7 Dental drugs, topically applied
0.010 0.990 0.001
Y56.6 Otorhinolaryngological drugs and preparations
0.010 0.990 0.001
Y56.5 Ophthalmological drugs and preparations
0.010 0.990 0.001
Y56.2 Local astringents and local detergents
0.010 0.990 0.001
Y56.1 Antipruritics
0.010 0.990 0.001
H90 Conductive and sensorineural hearing loss
0.010 0.990 0.000
Y44 Agents primarily affecting blood constituents
0.010 0.990 0.000
H83 Other diseases of inner ear
0.010 0.990 0.000
H94 Other disorders of ear in diseases classified elsewhere
0.010 0.990 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.010 0.990 0.000
H80-H83 Diseases of inner ear
0.010 0.990 0.000
Y53.4 Other laxatives
0.010 0.990 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.010 0.990 0.000
H90.5 Sensorineural hearing loss, unspecified
0.010 0.990 0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified
0.010 0.990 0.000
H95.1 Other disorders following mastoidectomy
0.009 0.991 0.000
Y57.7 Vitamins, not elsewhere classified
0.009 0.991 0.000
Y57.4 Pharmaceutical excipients
0.009 0.991 0.000
Y57.3 Alcohol deterrents
0.009 0.991 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.009 0.991 0.000
Y57.1 Lipotropic drugs
0.009 0.991 0.000
Y57.0 Appetite depressants [anorectics]
0.009 0.991 0.000
H72.2 Other marginal perforations of tympanic membrane
0.009 0.991 0.000
H60.8 Other otitis externa
0.009 0.991 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.009 0.991 0.000
H83.8 Other specified diseases of inner ear
0.009 0.991 0.000
H60.2 Malignant otitis externa
0.009 0.991 0.000
Y40.9 Systemic antibiotic, unspecified
0.000 0.991 0.009
H74.0 Tympanosclerosis
0.009 0.991 0.000
Y57.6 Other diagnostic agents
0.009 0.991 0.000
H93 Other disorders of ear, not elsewhere classified
0.009 0.991 0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity
0.009 0.991 0.000
Y46.2 Hydantoin derivatives
0.009 0.991 0.000
H67.8 Otitis media in other diseases classified elsewhere
0.009 0.991 0.000
H67.1 Otitis media in viral diseases classified elsewhere
0.009 0.991 0.000
H67.0 Otitis media in bacterial diseases classified elsewhere
0.009 0.991 0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.009 0.991 0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.009 0.991 0.000
H83.9 Disease of inner ear, unspecified
0.009 0.991 0.000
H83.0 Labyrinthitis
0.009 0.991 0.000
H72.1 Attic perforation of tympanic membrane
0.008 0.991 0.000
H73.0 Acute myringitis
0.008 0.991 0.000
H62 Disorders of external ear in diseases classified elsewhere
0.008 0.992 0.000
H66.3 Other chronic suppurative otitis media
0.008 0.992 0.000
Y48.4 Anaesthetic, unspecified
0.008 0.992 0.000
H95.8 Other postprocedural disorders of ear and mastoid process
0.008 0.992 0.000
H72.9 Perforation of tympanic membrane, unspecified
0.008 0.992 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.008 0.992 0.000
H68.0 Eustachian salpingitis
0.008 0.992 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.008 0.992 0.000
Y57.9 Drug or medicament, unspecified
0.008 0.992 0.000
M48 Other spondylopathies
0.008 0.992 0.000
Y41.5 Antiviral drugs
0.008 0.992 0.000
H74.9 Disorder of middle ear and mastoid, unspecified
0.008 0.992 0.000
H60.3 Other infective otitis externa
0.008 0.992 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.008 0.992 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.008 0.992 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.008 0.992 0.000
H73.1 Chronic myringitis
0.008 0.992 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.007 0.992 0.000
Y44.6 Natural blood and blood products
0.007 0.992 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.007 0.992 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.007 0.992 0.000
Y44.7 Plasma substitutes
0.007 0.992 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.007 0.992 0.000
H83.2 Labyrinthine dysfunction
0.007 0.993 0.000
H83.1 Labyrinthine fistula
0.007 0.993 0.000
Y54.5 Other diuretics
0.007 0.993 0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere
0.007 0.993 0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere
0.007 0.993 0.000
H82 Vertiginous syndromes in diseases classified elsewhere
0.007 0.993 0.000
H68.1 Obstruction of Eustachian tube
0.007 0.993 0.000
H93.3 Disorders of acoustic nerve
0.007 0.993 0.000
R03.1 Nonspecific low blood-pressure reading
0.007 0.993 0.000
H74.1 Adhesive middle ear disease
0.007 0.993 0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.007 0.993 0.000
M62.8 Other specified disorders of muscle
0.007 0.993 0.000
H93.2 Other abnormal auditory perceptions
0.007 0.993 0.000
H73.8 Other specified disorders of tympanic membrane
0.007 0.993 0.000
H90.0 Conductive hearing loss, bilateral
0.007 0.993 0.000
H93.8 Other specified disorders of ear
0.007 0.993 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.007 0.993 0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.007 0.993 0.000
M41.9 Scoliosis, unspecified
0.007 0.993 0.000
S82.80 Fractures of other parts of lower leg (closed)
0.007 0.993 0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.007 0.993 0.000
H83.3 Noise effects on inner ear
0.007 0.993 0.000
H93.0 Degenerative and vascular disorders of ear
0.007 0.993 0.000
Y43 Primarily systemic agents
0.007 0.993 0.000
H73.9 Disorder of tympanic membrane, unspecified
0.006 0.993 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.006 0.993 0.000
M48.9 Spondylopathy, unspecified
0.006 0.993 0.000
M62 Other disorders of muscle
0.006 0.994 0.000
M62.82 Other specified disorders of muscle (Upper arm)
0.006 0.994 0.000
H93.9 Disorder of ear, unspecified
0.006 0.994 0.000
H62.8 Other disorders of external ear in diseases classified elsewhere
0.006 0.994 0.000
H62.4 Otitis externa in other diseases classified elsewhere
0.006 0.994 0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere
0.006 0.994 0.000
H62.2 Otitis externa in mycoses
0.006 0.994 0.000
H62.1 Otitis externa in viral diseases classified elsewhere
0.006 0.994 0.000
M41.94 Scoliosis, unspecified (Thoracic region)
0.006 0.994 0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified
0.006 0.994 0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere
0.006 0.994 0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.006 0.994 0.000
M41 Scoliosis
0.006 0.994 0.000
M48.4 Fatigue fracture of vertebra
0.006 0.994 0.000
M48.3 Traumatic spondylopathy
0.006 0.994 0.000
M48.2 Kissing spine
0.006 0.994 0.000
M48.1 Ankylosing hyperostosis [Forestier]
0.006 0.994 0.000
M41.86 Other forms of scoliosis (Lumbar region)
0.006 0.994 0.000
H90.2 Conductive hearing loss, unspecified
0.006 0.994 0.000
H74.4 Polyp of middle ear
0.006 0.994 0.000
M41.8 Other forms of scoliosis
0.006 0.994 0.000
Y44.5 Thrombolytic drugs
0.005 0.994 0.000
M62.83 Other specified disorders of muscle (Forearm)
0.006 0.994 0.000
M62.1 Other rupture of muscle (nontraumatic)
0.006 0.994 0.000
M62.84 Other specified disorders of muscle (Hand)
0.005 0.994 0.000
M62.0 Diastasis of muscle
0.005 0.994 0.000
M62.81 Other specified disorders of muscle (Shoulder region)
0.005 0.994 0.000
A41.5 Septicaemia due to other Gram-negative organisms
0.006 0.994 0.000
H91 Other hearing loss
0.006 0.994 0.000
H60.1 Cellulitis of external ear
0.005 0.994 0.000
M62.87 Other specified disorders of muscle (Ankle and foot)
0.005 0.995 0.000
Y43.1 Antineoplastic antimetabolites
0.005 0.995 0.000
M48.99 Spondylopathy, unspecified (Site unspecified)
0.005 0.995 0.000
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)
0.005 0.995 0.000
Y43.2 Antineoplastic natural products
0.005 0.995 0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.005 0.995 0.000
M41.92 Scoliosis, unspecified (Cervical region)
0.005 0.995 0.000
M48.8 Other specified spondylopathies
0.005 0.995 0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.005 0.995 0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.005 0.995 0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.005 0.995 0.000
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)
0.005 0.995 0.000
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)
0.005 0.995 0.000
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)
0.005 0.995 0.000
M62.51 Muscle wasting and atrophy, not elsewhere classified (Shoulder region)
0.005 0.995 0.000
M62.80 Other specified disorders of muscle (Multiple sites)
0.005 0.995 0.000
H80 Otosclerosis
0.005 0.995 0.000
K37 Unspecified appendicitis
0.005 0.995 0.000
Y43.9 Primarily systemic agent, unspecified
0.005 0.995 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.005 0.995 0.000
Y43.6 Enzymes, not elsewhere classified
0.005 0.995 0.000
Y43.5 Acidifying and alkalising agents
0.005 0.995 0.000
M48.96 Spondylopathy, unspecified (Lumbar region)
0.005 0.995 0.000
M62.08 Diastasis of muscle (Other)
0.005 0.995 0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.005 0.995 0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)
0.005 0.995 0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)
0.005 0.995 0.000
M48.94 Spondylopathy, unspecified (Thoracic region)
0.005 0.995 0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)
0.005 0.995 0.000
M48.92 Spondylopathy, unspecified (Cervical region)
0.005 0.995 0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)
0.005 0.995 0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)
0.005 0.995 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.000 0.995 0.005
M62.12 Other rupture of muscle (nontraumatic) (Upper arm)
0.005 0.995 0.000
M62.4 Contracture of muscle
0.005 0.995 0.000
M62.3 Immobility syndrome (paraplegic)
0.005 0.995 0.000
M62.2 Ischaemic infarction of muscle
0.005 0.995 0.000
M41.99 Scoliosis, unspecified (Site unspecified)
0.005 0.995 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.003 0.995 0.002
M62.11 Other rupture of muscle (nontraumatic) (Shoulder region)
0.005 0.995 0.000
M41.4 Neuromuscular scoliosis
0.005 0.995 0.000
O24.4 Diabetes mellitus arising in pregnancy
0.000 0.995 0.005
H91.8 Other specified hearing loss
0.005 0.995 0.000
M62.58 Muscle wasting and atrophy, not elsewhere classified (Other)
0.005 0.995 0.000
M62.57 Muscle wasting and atrophy, not elsewhere classified (Ankle and foot)
0.005 0.995 0.000
M62.53 Muscle wasting and atrophy, not elsewhere classified (Forearm)
0.005 0.995 0.000
M62.52 Muscle wasting and atrophy, not elsewhere classified (Upper arm)
0.005 0.995 0.000
M62.9 Disorder of muscle, unspecified
0.005 0.995 0.000
M41.3 Thoracogenic scoliosis
0.004 0.995 0.000
M41.2 Other idiopathic scoliosis
0.004 0.995 0.000
M41.1 Juvenile idiopathic scoliosis
0.004 0.995 0.000
M41.0 Infantile idiopathic scoliosis
0.004 0.995 0.000
M41.96 Scoliosis, unspecified (Lumbar region)
0.005 0.995 0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)
0.004 0.995 0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)
0.004 0.995 0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)
0.004 0.995 0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)
0.004 0.995 0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)
0.004 0.995 0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)
0.004 0.995 0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)
0.004 0.995 0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)
0.004 0.995 0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)
0.004 0.995 0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)
0.004 0.995 0.000
M48.29 Kissing spine (Site unspecified)
0.004 0.995 0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)
0.004 0.995 0.000
M48.27 Kissing spine (Lumbosacral region)
0.004 0.995 0.000
M48.26 Kissing spine (Lumbar region)
0.004 0.995 0.000
M48.25 Kissing spine (Thoracolumbar region)
0.004 0.995 0.000
M48.24 Kissing spine (Thoracic region)
0.004 0.995 0.000
M48.23 Kissing spine (Cervicothoracic region)
0.004 0.995 0.000
M48.22 Kissing spine (Cervical region)
0.004 0.995 0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)
0.004 0.995 0.000
M48.20 Kissing spine (Multiple sites in spine)
0.004 0.995 0.000
M48.39 Traumatic spondylopathy (Site unspecified)
0.004 0.995 0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)
0.004 0.995 0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)
0.004 0.995 0.000
M48.36 Traumatic spondylopathy (Lumbar region)
0.004 0.995 0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)
0.004 0.995 0.000
M48.34 Traumatic spondylopathy (Thoracic region)
0.004 0.995 0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)
0.004 0.995 0.000
M48.32 Traumatic spondylopathy (Cervical region)
0.004 0.995 0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)
0.004 0.995 0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)
0.004 0.995 0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)
0.004 0.995 0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)
0.004 0.995 0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)
0.004 0.995 0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)
0.004 0.995 0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)
0.004 0.995 0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)
0.004 0.995 0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)
0.004 0.995 0.000
M48.42 Fatigue fracture of vertebra (Cervical region)
0.004 0.995 0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)
0.004 0.995 0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)
0.004 0.995 0.000
D23.1 Skin of eyelid, including canthus
0.005 0.995 0.000
M41.85 Other forms of scoliosis (Thoracolumbar region)
0.004 0.995 0.000
M62.6 Muscle strain
0.004 0.995 0.000
M41.89 Other forms of scoliosis (Site unspecified)
0.004 0.995 0.000
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)
0.004 0.995 0.000
M41.87 Other forms of scoliosis (Lumbosacral region)
0.004 0.995 0.000
M41.84 Other forms of scoliosis (Thoracic region)
0.004 0.995 0.000
M41.83 Other forms of scoliosis (Cervicothoracic region)
0.004 0.995 0.000
M41.82 Other forms of scoliosis (Cervical region)
0.004 0.995 0.000
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)
0.004 0.995 0.000
M41.80 Other forms of scoliosis (Multiple sites in spine)
0.004 0.995 0.000
Y57.5 X-ray contrast media
0.004 0.995 0.001
M62.86 Other specified disorders of muscle (Lower leg)
0.004 0.996 0.000
M62.19 Other rupture of muscle (nontraumatic) (Site unspecified)
0.004 0.996 0.000
M62.18 Other rupture of muscle (nontraumatic) (Other)
0.004 0.996 0.000
M62.17 Other rupture of muscle (nontraumatic) (Ankle and foot)
0.004 0.996 0.000
M62.16 Other rupture of muscle (nontraumatic) (Lower leg)
0.004 0.996 0.000
M62.15 Other rupture of muscle (nontraumatic) (Pelvic region and thigh)
0.004 0.996 0.000
M62.14 Other rupture of muscle (nontraumatic) (Hand)
0.004 0.996 0.000
M62.13 Other rupture of muscle (nontraumatic) (Forearm)
0.004 0.996 0.000
M62.10 Other rupture of muscle (nontraumatic) (Multiple sites)
0.004 0.996 0.000
H91.2 Sudden idiopathic hearing loss
0.004 0.996 0.000
M41.5 Other secondary scoliosis
0.004 0.996 0.000
Y43.0 Antiallergic and antiemetic drugs
0.004 0.996 0.000
Y40 Systemic antibiotics
0.003 0.996 0.001
M62.09 Diastasis of muscle (Site unspecified)
0.004 0.996 0.000
M62.07 Diastasis of muscle (Ankle and foot)
0.004 0.996 0.000
M62.06 Diastasis of muscle (Lower leg)
0.004 0.996 0.000
M62.05 Diastasis of muscle (Pelvic region and thigh)
0.004 0.996 0.000
M62.04 Diastasis of muscle (Hand)
0.004 0.996 0.000
M62.03 Diastasis of muscle (Forearm)
0.004 0.996 0.000
M62.02 Diastasis of muscle (Upper arm)
0.004 0.996 0.000
M62.01 Diastasis of muscle (Shoulder region)
0.004 0.996 0.000
M62.00 Diastasis of muscle (Multiple sites)
0.004 0.996 0.000
C22.1 Intrahepatic bile duct carcinoma
0.000 0.996 0.004
M48.82 Other specified spondylopathies (Cervical region)
0.004 0.996 0.000
H91.0 Ototoxic hearing loss
0.004 0.996 0.000
C09.9 Tonsil, unspecified
0.004 0.996 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.996 0.004
H91.3 Deaf mutism, not elsewhere classified
0.004 0.996 0.000
Q07.0 Arnold-Chiari syndrome
0.004 0.996 0.000
M48.5 Collapsed vertebra, not elsewhere classified
0.004 0.996 0.000
M48.89 Other specified spondylopathies (Site unspecified)
0.004 0.996 0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)
0.004 0.996 0.000
M48.84 Other specified spondylopathies (Thoracic region)
0.004 0.996 0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)
0.004 0.996 0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)
0.004 0.996 0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)
0.004 0.996 0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)
0.004 0.996 0.000
H80.8 Other otosclerosis
0.004 0.996 0.000
H80.2 Cochlear otosclerosis
0.004 0.996 0.000
H80.1 Otosclerosis involving oval window, obliterative
0.004 0.996 0.000
H80.0 Otosclerosis involving oval window, nonobliterative
0.004 0.996 0.000
O24 Diabetes mellitus in pregnancy
0.000 0.996 0.004
M40-M43 Deforming dorsopathies
0.004 0.996 0.000
O24.9 Diabetes mellitus in pregnancy, unspecified
0.000 0.996 0.004
M41.49 Neuromuscular scoliosis (Site unspecified)
0.004 0.996 0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent
0.000 0.996 0.004
M62.29 Ischaemic infarction of muscle (Site unspecified)
0.004 0.996 0.000
M62.28 Ischaemic infarction of muscle (Other)
0.004 0.996 0.000
M62.27 Ischaemic infarction of muscle (Ankle and foot)
0.004 0.996 0.000
M62.26 Ischaemic infarction of muscle (Lower leg)
0.004 0.996 0.000
M62.25 Ischaemic infarction of muscle (Pelvic region and thigh)
0.004 0.996 0.000
M62.24 Ischaemic infarction of muscle (Hand)
0.004 0.996 0.000
M62.23 Ischaemic infarction of muscle (Forearm)
0.004 0.996 0.000
M62.22 Ischaemic infarction of muscle (Upper arm)
0.004 0.996 0.000
M62.21 Ischaemic infarction of muscle (Shoulder region)
0.004 0.996 0.000
M62.20 Ischaemic infarction of muscle (Multiple sites)
0.004 0.996 0.000
M62.39 Immobility syndrome (paraplegic) (Site unspecified)
0.004 0.996 0.000
M62.38 Immobility syndrome (paraplegic) (Other)
0.004 0.996 0.000
M62.37 Immobility syndrome (paraplegic) (Ankle and foot)
0.004 0.996 0.000
M62.36 Immobility syndrome (paraplegic) (Lower leg)
0.004 0.996 0.000
M62.35 Immobility syndrome (paraplegic) (Pelvic region and thigh)
0.004 0.996 0.000
M62.34 Immobility syndrome (paraplegic) (Hand)
0.004 0.996 0.000
M62.33 Immobility syndrome (paraplegic) (Forearm)
0.004 0.996 0.000
M62.32 Immobility syndrome (paraplegic) (Upper arm)
0.004 0.996 0.000
M62.31 Immobility syndrome (paraplegic) (Shoulder region)
0.004 0.996 0.000
M62.30 Immobility syndrome (paraplegic) (Multiple sites)
0.004 0.996 0.000
M62.49 Contracture of muscle (Site unspecified)
0.004 0.996 0.000
M62.48 Contracture of muscle (Other)
0.004 0.996 0.000
M62.47 Contracture of muscle (Ankle and foot)
0.004 0.996 0.000
M62.46 Contracture of muscle (Lower leg)
0.004 0.996 0.000
M62.45 Contracture of muscle (Pelvic region and thigh)
0.004 0.996 0.000
M62.44 Contracture of muscle (Hand)
0.004 0.996 0.000
M62.43 Contracture of muscle (Forearm)
0.004 0.996 0.000
M62.42 Contracture of muscle (Upper arm)
0.004 0.996 0.000
M62.41 Contracture of muscle (Shoulder region)
0.004 0.996 0.000
M62.40 Contracture of muscle (Multiple sites)
0.004 0.996 0.000
Y44.2 Anticoagulants
0.004 0.996 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.003 0.996 0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)
0.003 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.